Literature DB >> 22483619

mRNA decapping factors and the exonuclease Xrn2 function in widespread premature termination of RNA polymerase II transcription.

Kris Brannan1, Hyunmin Kim, Benjamin Erickson, Kira Glover-Cutter, Soojin Kim, Nova Fong, Lauren Kiemele, Kirk Hansen, Richard Davis, Jens Lykke-Andersen, David L Bentley.   

Abstract

We report a function of human mRNA decapping factors in control of transcription by RNA polymerase II. Decapping proteins Edc3, Dcp1a, and Dcp2 and the termination factor TTF2 coimmunoprecipitate with Xrn2, the nuclear 5'-3' exonuclease "torpedo" that facilitates transcription termination at the 3' ends of genes. Dcp1a, Xrn2, and TTF2 localize near transcription start sites (TSSs) by ChIP-seq. At genes with 5' peaks of paused pol II, knockdown of decapping or termination factors Xrn2 and TTF2 shifted polymerase away from the TSS toward upstream and downstream distal positions. This redistribution of pol II is similar in magnitude to that caused by depletion of the elongation factor Spt5. We propose that coupled decapping of nascent transcripts and premature termination by the "torpedo" mechanism is a widespread mechanism that limits bidirectional pol II elongation. Regulated cotranscriptional decapping near promoter-proximal pause sites followed by premature termination could control productive pol II elongation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22483619      PMCID: PMC3806456          DOI: 10.1016/j.molcel.2012.03.006

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  60 in total

Review 1.  Transcription attenuation: once viewed as a novel regulatory strategy.

Authors:  C Yanofsky
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

2.  RNA-binding protein Nrd1 directs poly(A)-independent 3'-end formation of RNA polymerase II transcripts.

Authors:  E J Steinmetz; N K Conrad; D A Brow; J L Corden
Journal:  Nature       Date:  2001-09-20       Impact factor: 49.962

3.  Dynamic association of capping enzymes with transcribing RNA polymerase II.

Authors:  S C Schroeder; B Schwer; S Shuman; D Bentley
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

4.  Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay.

Authors:  Jens Lykke-Andersen
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

5.  A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells.

Authors:  D L Bentley; M Groudine
Journal:  Nature       Date:  1986 Jun 12-18       Impact factor: 49.962

Review 6.  Transcription termination and anti-termination in E. coli.

Authors:  Evgeny Nudler; Max E Gottesman
Journal:  Genes Cells       Date:  2002-08       Impact factor: 1.891

7.  The RNA processing exosome is linked to elongating RNA polymerase II in Drosophila.

Authors:  Erik D Andrulis; Janis Werner; Arpi Nazarian; Hediye Erdjument-Bromage; Paul Tempst; John T Lis
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  hLodestar/HuF2 interacts with CDC5L and is involved in pre-mRNA splicing.

Authors:  Deana Leonard; Paul Ajuh; Angus I Lamond; Randy J Legerski
Journal:  Biochem Biophys Res Commun       Date:  2003-09-05       Impact factor: 3.575

9.  The hDcp2 protein is a mammalian mRNA decapping enzyme.

Authors:  Zuoren Wang; Xinfu Jiao; Anne Carr-Schmid; Megerditch Kiledjian
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-06       Impact factor: 11.205

10.  A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.

Authors:  Zirong Li; Sara Van Calcar; Chunxu Qu; Webster K Cavenee; Michael Q Zhang; Bing Ren
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

View more
  122 in total

1.  Effects of Transcription Elongation Rate and Xrn2 Exonuclease Activity on RNA Polymerase II Termination Suggest Widespread Kinetic Competition.

Authors:  Nova Fong; Kristopher Brannan; Benjamin Erickson; Hyunmin Kim; Michael A Cortazar; Ryan M Sheridan; Tram Nguyen; Shai Karp; David L Bentley
Journal:  Mol Cell       Date:  2015-10-15       Impact factor: 17.970

Review 2.  PIWI-interacting RNAs: from generation to transgenerational epigenetics.

Authors:  Maartje J Luteijn; René F Ketting
Journal:  Nat Rev Genet       Date:  2013-06-25       Impact factor: 53.242

3.  Premature termination of transcription by RNAP II: the beginning of the end.

Authors:  Xavier Contreras; Monsef Benkirane; Rosemary Kiernan
Journal:  Transcription       Date:  2013 Mar-Apr

Review 4.  RNA polymerase II transcription elongation control.

Authors:  Jiannan Guo; David H Price
Journal:  Chem Rev       Date:  2013-08-06       Impact factor: 60.622

Review 5.  Transcriptional elongation checkpoint control in development and disease.

Authors:  Edwin Smith; Ali Shilatifard
Journal:  Genes Dev       Date:  2013-05-15       Impact factor: 11.361

Review 6.  Transcription termination and the control of the transcriptome: why, where and how to stop.

Authors:  Odil Porrua; Domenico Libri
Journal:  Nat Rev Mol Cell Biol       Date:  2015-02-04       Impact factor: 94.444

7.  Argonaute-bound small RNAs from promoter-proximal RNA polymerase II.

Authors:  Jesse R Zamudio; Timothy J Kelly; Phillip A Sharp
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

8.  Transcriptional Pause Sites Delineate Stable Nucleosome-Associated Premature Polyadenylation Suppressed by U1 snRNP.

Authors:  Anthony C Chiu; Hiroshi I Suzuki; Xuebing Wu; Dig B Mahat; Andrea J Kriz; Phillip A Sharp
Journal:  Mol Cell       Date:  2018-02-01       Impact factor: 17.970

9.  Judge, jury, and executioner: DXO functions as a decapping enzyme and exoribonuclease in pre-mRNA quality control.

Authors:  Jeffrey S Mugridge; John D Gross
Journal:  Mol Cell       Date:  2013-04-11       Impact factor: 17.970

10.  Defining the status of RNA polymerase at promoters.

Authors:  Leighton J Core; Joshua J Waterfall; Daniel A Gilchrist; David C Fargo; Hojoong Kwak; Karen Adelman; John T Lis
Journal:  Cell Rep       Date:  2012-10-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.